This year's largest Biotechnology Industry event is held in San Diego, CA
Edmonton, June 14, 2017
– KMT Hepatech, Inc., a Canadian biotechnology company offering in vivo research services utilizing proprietary KMT MouseTM
(uPA/SCID mouse model with stable human hepatocyte engraftment of up to 95 per cent), announced that representative from the company will be participating in the BIO International Convention. Dr. Svetlana Sapelnikova (Director, Marketing / Business Development) will take part in the pre-scheduled meetings at BIO International convention held June 19-22, 2017 in San Diego, California.
Companies or individuals attending BIO One-on-One Partnering can schedule meeting with KMT Hepatech visiting http://convention.bio.org/partner/
For companies or individuals not participating in partnering meetings, KMT Hepatech may be available to meet within Canada Pavilion in booth #4325
(at BioAlberta section). For the exhibition hall schedule, visit http://convention.bio.org/exhibit/
For more details on KMT Hepatech services visit our website page
Also enquire about supplying freshly isolated or cryopreserved (suspension or plateable grade) human hepatocytes derived from chimeric mouse for in vitro studies – email
About KMT Hepatech, Inc.: A private company providing in vivo research services utilizing proprietary platform technology of the chimeric mouse model with highly humanized liver. Due to the expanding interest in the humanized liver mouse model across a wide range of drug development fields, the company now offers services in infectious diseases (hepatitis, malaria), early assessment of human hepatotoxicity and characterization of human-type drug metabolism. Freshly isolated or cryopreserved (suspension or plateable grade) human hepatocytes derived from chimeric mouse can be supplied for in vitro studies.
Dr. Svetlana Sapelnikova
KMT Hepatech, Inc.
+1 (780) 641 1917